These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9542668)

  • 1. Protein C and protein S activities in Behçet's disease as risk factors of thrombosis.
    Lenk N; Ozet G; Alli N; Coban O; Erbaşi S
    Int J Dermatol; 1998 Feb; 37(2):124-5. PubMed ID: 9542668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
    Mader R; Ziv M; Adawi M; Mader R; Lavi I
    J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on thrombophilic factors in Italian Behcet's patients.
    Caramaschi P; Poli G; Bonora A; Volpe A; Tinazzi I; Pieropan S; Bambara LM; Biasi D
    Joint Bone Spine; 2010 Jul; 77(4):330-4. PubMed ID: 20452800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
    Atıl A; Deniz A
    Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C resistance and its correlation with thrombophlebitis in Behçet's disease.
    Kavala M; Namdar ND; Kocatürk E; Türkoğlu Z; Zindanci I
    Acta Dermatovenerol Croat; 2011; 19(2):87-90. PubMed ID: 21703154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state.
    Ozatli D; Sayinalp N; Büyükaşik Y; Karakuş S; Haznedaroglu IC; Kirazli S; Ozcebe O; Dündar SV
    Rheumatol Int; 2002 Jan; 21(4):137-40. PubMed ID: 11843168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased protein S activity is related to the disease activity of Behcet's disease.
    Kwon SR; Lim MJ; Park SG; Moon YS; Park W
    Rheumatol Int; 2006 Nov; 27(1):39-43. PubMed ID: 16969634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein S deficiency and antibodies to protein S in patients with Behçet's disease.
    Guermazi S; Hamza M; Dellagi K
    Thromb Res; 1997 May; 86(3):197-204. PubMed ID: 9175241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinaemia in Behçet's disease.
    Aksu K; Turgan N; Oksel F; Keser G; Ozmen D; Kitapçioğlu G; Gümüşdiş G; Bayindir O; Doğanavşargil E
    Rheumatology (Oxford); 2001 Jun; 40(6):687-90. PubMed ID: 11426028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why are male patients with Behçet's disease prone to thrombosis? A rotational thromboelastographic analysis.
    Kara Kivanc B; Gönüllü E; Akay OM; Ertürk A; Bal C; Cansu DÜ; Korkmaz C
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):63-67. PubMed ID: 29998845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare but serious manifestation of Behçet's disease: intracardiac thrombus in 22 patients.
    Emmungil H; Yaşar Bilge NŞ; Küçükşahin O; Kılıç L; Okutucu S; Gücenmez S; Kalyoncu U; Kaşifoğlu T; Turgay M; Aksu K
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S87-92. PubMed ID: 25068833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement.
    Sengül N; Demirer S; Yerdel MA; Terzioğlu G; Akin B; Gürler A; Tüzüner A
    World J Surg; 2000 Dec; 24(12):1584-8. PubMed ID: 11193728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation parameters and plasma total homocysteine levels in Behcet's disease.
    Lee YJ; Kang SW; Yang JI; Choi YM; Sheen D; Lee EB; Choi SW; Song YW
    Thromb Res; 2002 Apr; 106(1):19-24. PubMed ID: 12165284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease.
    Gül A; Ozbek U; Oztürk C; Inanç M; Koniçe M; Ozçelik T
    Br J Rheumatol; 1996 Nov; 35(11):1178-80. PubMed ID: 8948311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease.
    Nalçaci M; Pekçelen Y
    J Int Med Res; 1998; 26(4):206-8. PubMed ID: 9818787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinaemia and activated protein C resistance in Behçet's disease.
    Altinbaş A; Aytemur K; Tokgözoğlu L; Oztürk M; Koşar A; Haznedaroğlu IC; Kirazli S; Dündar SV
    J Intern Med; 2000 Sep; 248(3):267-8. PubMed ID: 10971795
    [No Abstract]   [Full Text] [Related]  

  • 19. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.